Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Malignant pleural mesothelioma (MPM) is a rare neoplasm. Its initial symptomatology often
mimics tuberculosis, including pleural effusion, and is frequently treated as tuberculosis in …

Background Malignant pleural mesothelioma incidence continues to rise, with few available
evidence-based therapeutic options. Results of previous non-randomised studies suggested …

Study objectives Thoracoscopic pleural biopsy is highly accurate in the diagnosis of pleural
malignancy. However, no scientific evidence is currently available to guide the physician's …

Objective: The diagnostic approach to pleural diseases may be difficult. The CT scan, which
is the current diagnostic technique, has limited accuracy both in the differentiation between …

Thoracoscopy has provided chest physicians and surgeons with an opportunity to rethink
their approach to patients with pleural and pulmonary disease. In this brief review, several …

Diffuse malignant pleural mesothelioma (DMPM) is a challenging disease in all of its
aspects, from presentation and diagnosis to staging and treatment. Single-modality therapy …

Learning Objectives After completing this course, the reader will be able to: Select
appropriate treatment strategies for patients with MPM. Discuss the clinical development of …

Objective: Malignant pleural mesothelioma is a fatal disease with a mean life expectancy of
6–12 months. Since 1982, we have performed thoracoscopic talc poudrage (TTP) as a …

Malignant pleural mesothelioma (MPM) is a uniformly fatal disease that has been
recalcitrant to curative therapies. Median survivals of 8–18 months have, for the most part …